Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance
OC-2026-135574 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A NAICS 61143 solicitation, performed in Silver Spring, MD, with responses due 2026-07-28. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
The U.S. Food and Drug Administration's (FDA), Office of Acquisitions and Grants Services (OAGS), is conducting market research for obtaining Global Abbreviated New Drug Application (ANDA) Training Program services. THIS IS A SOURCES SOUGHT NOTICE (SSN) ONLY. This SSN is being issued in accordance w
Comparable recent awards in NAICS 61143
| Winner | Award value | Offers | Date |
|---|---|---|---|
| Detail available to signed-in users. | |||
Questions
What is solicitation OC-2026-135574?
Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 61143 (NAICS 61143), performed in Silver Spring, MD. Responses are due 2026-07-28.
Is OC-2026-135574 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.